Clinical Trial: Fezolinetant and Vascular Health and Brain Health

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606664) titled 'Fezolinetant and Vascular Health and Brain Health' on May 18.

Brief Summary: The goal of this clinical trial is to learn whether a study drug called fezolinetant impacts cardiovascular and cognitive health in women who have moderate to severe menopausal hot flashes and night sweats.

Researchers will compare fezolinetant to a placebo. A placebo is a pill that looks like the study drug but does not contain any active medicine. This comparison helps researchers understand whether fezolinetant works better than no treatment.

Participants will:

Be randomly assigned to take either fezolinetant (45 mg) or a placebo once a day for 12 week...